Vivani Medical (VANI) Non-Current Deferred Tax Liability (2021 - 2023)
Vivani Medical (VANI) posted quarterly Non-Current Deferred Tax Liability of $2.1 million for Q4 2023, up 24.07% year-over-year from $1.7 million in Q4 2022, and up 24.07% quarter-over-quarter from $1.7 million in Q4 2022.
Vivani Medical (VANI) Non-Current Deferred Tax Liability (2021 - 2023) Analysis & Trends
Vivani Medical's Non-Current Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $2.1 million for Q4 2023.
- In Q4 2023, Non-Current Deferred Tax Liability rose 24.07% year-over-year to $2.1 million; the TTM figure through Dec 2023 stood at $2.1 million (up 24.07% YoY), while the FY2023 annual figure was $2.1 million, up 24.07% from the prior year.
- Non-Current Deferred Tax Liability for Q4 2023 stood at $2.1 million, up from $1.7 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $2.1 million in Q4 2023, with the low at $120000.0 in Q4 2021.
- The 3-year median for Non-Current Deferred Tax Liability is $1.7 million (2022), against an average of $1.3 million.
- The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability soared 1326.67% in 2022, then increased 24.07% in 2023.
- Vivani Medical's Non-Current Deferred Tax Liability stood at $120000.0 in 2021, then jumped by 1326.67% to $1.7 million in 2022, then climbed by 24.07% to $2.1 million in 2023.
- Business Quant data shows VANI's Non-Current Deferred Tax Liability at $2.1 million in Q4 2023, $1.7 million in Q4 2022, and $120000.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.12 Mn |
| Dec 31, 2023 | 2.12 Mn |
| Dec 31, 2022 | 1.71 Mn |
| Dec 31, 2022 | 1.71 Mn |
| Dec 31, 2021 | 120,000.00 |
| Dec 31, 2021 | 120,000.00 |